About this FactMed analysis covering adverse side effect reports of AGGRENOX patients who developed LEUKOPENIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 7 individuals taking AGGRENOX reported LEUKOPENIA to the FDA. A total of 3940 AGGRENOX drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AGGRENOX and LEUKOPENIA. In doing so, we compare AGGRENOX with other drugs that cause LEUKOPENIA, to help you evaluate whether or not AGGRENOX causes LEUKOPENIA. Likewise, this page shows the most highly-reported side effects of AGGRENOX, so you can see if LEUKOPENIA ranks among AGGRENOX's most well-known side effects.
Summary Statistics
Reports of AGGRENOX causing LEUKOPENIA: 7
Reports of any side effect of AGGRENOX : 3940
Percentage of AGGRENOX patients where LEUKOPENIA is a reported side effect: 0.1777%

FDA reports of any drug causing LEUKOPENIA : 16278
Average percentage for all medicated patients where LEUKOPENIA is reported as a complication: 0.1020%

Physician opinion on AGGRENOX as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AGGRENOX:
CEREBROVASCULAR ACCIDENT PROPHYLAXIS ( 573 patients )
TRANSIENT ISCHAEMIC ATTACK ( 426 patients )
CEREBROVASCULAR ACCIDENT ( 325 patients )
PROPHYLAXIS ( 114 patients )
DRUG USE FOR UNKNOWN INDICATION ( 81 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 80 patients )
ANTICOAGULANT THERAPY ( 71 patients )
THROMBOSIS PROPHYLAXIS ( 25 patients )
ANTIPLATELET THERAPY ( 24 patients )
ISCHAEMIC STROKE ( 14 patients )
CAROTID ARTERY OCCLUSION ( 14 patients )
HYPERTENSION ( 12 patients )
ISCHAEMIC CEREBRAL INFARCTION ( 11 patients )
ATRIAL FIBRILLATION ( 11 patients )
CORONARY ARTERY DISEASE ( 9 patients )
CEREBRAL INFARCTION ( 7 patients )
VASCULAR SHUNT ( 7 patients )
ARTERIAL DISORDER ( 7 patients )
THROMBOSIS ( 7 patients )
LACUNAR INFARCTION ( 6 patients )
CARDIAC DISORDER ( 5 patients )
PLATELET AGGREGATION ABNORMAL ( 5 patients )
ANGIOPATHY ( 5 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 5 patients )
CEREBRAL ISCHAEMIA ( 5 patients )
CEREBROVASCULAR DISORDER ( 4 patients )
CARDIOVASCULAR DISORDER ( 4 patients )
CEREBROVASCULAR INSUFFICIENCY ( 4 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 4 patients )
CAROTID ARTERY STENOSIS ( 3 patients )
HYPERHOMOCYSTEINAEMIA ( 3 patients )
HYPOAESTHESIA FACIAL ( 3 patients )
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT ( 3 patients )
EPILEPSY ( 3 patients )
COAGULOPATHY ( 3 patients )
HEMIPARESIS ( 3 patients )
DIZZINESS ( 3 patients )
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ( 2 patients )
PHLEBITIS SUPERFICIAL ( 2 patients )
VARICOSE VEIN ( 2 patients )
CAROTID ARTERY DISEASE ( 2 patients )
MIGRAINE ( 2 patients )
CEREBRAL HAEMORRHAGE ( 2 patients )
BLOOD PRESSURE ( 2 patients )
SPEECH DISORDER ( 2 patients )
PAIN ( 2 patients )
CEREBRAL THROMBOSIS ( 2 patients )
PERIPHERAL ISCHAEMIA ( 2 patients )
ARTERY DISSECTION ( 2 patients )
VASCULAR CALCIFICATION ( 2 patients )
CONVULSION ( 2 patients )
ANGINA PECTORIS ( 2 patients )
CEREBELLAR INFARCTION ( 2 patients )
POST PROCEDURAL STROKE ( 2 patients )
HYPOAESTHESIA ( 2 patients )
BLOOD DISORDER ( 2 patients )
HYPOPERFUSION ( 2 patients )
OPTIC NERVE INFARCTION ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
ENZYME ABNORMALITY ( 2 patients )
ESSENTIAL THROMBOCYTHAEMIA ( 1 patients )
ARTERIAL STENOSIS ( 1 patients )
THYROID STIMULATING IMMUNOGLOBULIN ( 1 patients )
FEELING ABNORMAL ( 1 patients )
ARTHRITIS ( 1 patients )
CEREBROVASCULAR STENOSIS ( 1 patients )
HAEMODILUTION ( 1 patients )
ATRIAL FLUTTER ( 1 patients )
CONCUSSION ( 1 patients )
MEMORY IMPAIRMENT ( 1 patients )
VASCULAR DEMENTIA ( 1 patients )
AMNESIA ( 1 patients )
PLATELET COUNT ( 1 patients )
BALANCE DISORDER ( 1 patients )
VASCULITIS ( 1 patients )
CEREBRAL ARTERIOSCLEROSIS ( 1 patients )
BASAL GANGLION DEGENERATION ( 1 patients )
DIALYSIS ( 1 patients )
MUSCULAR WEAKNESS ( 1 patients )
VERTIGO ( 1 patients )
OFF LABEL USE ( 1 patients )
AORTIC VALVE REPLACEMENT ( 1 patients )
HYPOTENSION ( 1 patients )
BRAIN STEM INFARCTION ( 1 patients )
EMBOLIC STROKE ( 1 patients )
ARRHYTHMIA ( 1 patients )
INFARCTION ( 1 patients )
THROMBOEMBOLIC STROKE ( 1 patients )
BRAIN STEM SYNDROME ( 1 patients )
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ( 1 patients )
ARTERIAL OCCLUSIVE DISEASE ( 1 patients )
ISCHAEMIA ( 1 patients )
CARDIOMYOPATHY ( 1 patients )
EYE DISORDER ( 1 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 1 patients )
PLASMA VISCOSITY DECREASED ( 1 patients )
AMAUROSIS FUGAX ( 1 patients )
PLATELET AGGREGATION INHIBITION ( 1 patients )
ATRIAL SEPTAL DEFECT REPAIR ( 1 patients )
MICROANGIOPATHY ( 1 patients )
HYPERLIPIDAEMIA ( 1 patients )
BASAL GANGLIA INFARCTION ( 1 patients )
DEEP VEIN THROMBOSIS ( 1 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 1 patients )
VASCULITIS CEREBRAL ( 1 patients )
CEREBRAL ATHEROSCLEROSIS ( 1 patients )
NERVOUS SYSTEM DISORDER ( 1 patients )
VISUAL IMPAIRMENT ( 1 patients )
ANXIETY ( 1 patients )
CEREBRAL HYPOPERFUSION ( 1 patients )
RUPTURED CEREBRAL ANEURYSM ( 1 patients )
BLOOD PRESSURE ABNORMAL ( 1 patients )
DYSARTHRIA ( 1 patients )
APHASIA ( 1 patients )
STENT PLACEMENT ( 1 patients )
BRAIN STEM ISCHAEMIA ( 1 patients )
PARAESTHESIA ( 1 patients )
INFLAMMATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with LEUKOPENIA:

CLOZAPINE (1587 patients)
DEXAMETHASONE (991 patients)
FLUOROURACIL (976 patients)
CYCLOPHOSPHAMIDE (927 patients)
PREDNISONE (906 patients)
CISPLATIN (834 patients)
ASPIRIN (816 patients)
ZOMETA (768 patients)
METHOTREXATE (727 patients)
SEROQUEL (725 patients)
PREDNISOLONE (719 patients)
LASIX (644 patients)
REVLIMID (635 patients)
OMEPRAZOLE (616 patients)
CARBOPLATIN (597 patients)
MYCOPHENOLATE MOFETIL (557 patients)
ZYPREXA (540 patients)
HEPARIN SODIUM INJECTION (529 patients)
CYCLOSPORINE (519 patients)
FOSAMAX (511 patients)
RISPERDAL (499 patients)
AREDIA (499 patients)
FOLIC ACID (484 patients)
LORAZEPAM (479 patients)
DECADRON (472 patients)
ACETAMINOPHEN (455 patients)
NEXIUM (436 patients)
FUROSEMIDE (433 patients)
ALLOPURINOL (424 patients)
REMICADE (417 patients)
DOXORUBICIN HCL (415 patients)
CLOZARIL (391 patients)
VIOXX (391 patients)
DOCETAXEL (382 patients)
OXALIPLATIN (380 patients)
ETOPOSIDE (379 patients)
NEUPOGEN (365 patients)
PROTONIX (356 patients)
LEVOTHYROXINE SODIUM (351 patients)
VELCADE (350 patients)
RITUXIMAB (349 patients)
NEORAL (348 patients)
AZATHIOPRINE (347 patients)
ZOFRAN (343 patients)
OXYCONTIN (340 patients)
COUMADIN (339 patients)
PREDNISONE TAB (330 patients)
POTASSIUM CHLORIDE (330 patients)
LIPITOR (328 patients)
VINCRISTINE (322 patients)
KEPPRA (320 patients)
FLUCONAZOLE (316 patients)
NEURONTIN (315 patients)
BACTRIM (312 patients)
PACLITAXEL (311 patients)
RIBAVIRIN (307 patients)
PEGASYS (298 patients)
LEUCOVORIN CALCIUM (291 patients)
VANCOMYCIN (290 patients)
IRINOTECAN HCL (278 patients)
TAXOTERE (274 patients)
GLEEVEC (271 patients)
LISINOPRIL (270 patients)
SIMVASTATIN (268 patients)
TEGRETOL (267 patients)
ACYCLOVIR (264 patients)
THALIDOMIDE (263 patients)
GABAPENTIN (259 patients)
ATENOLOL (259 patients)
XANAX (256 patients)
TACROLIMUS (255 patients)
HUMIRA (254 patients)
METHYLPREDNISOLONE (250 patients)
PRILOSEC (250 patients)
ARANESP (240 patients)
NORVASC (239 patients)
CIPROFLOXACIN (238 patients)
CELLCEPT (237 patients)
HYDROCHLOROTHIAZIDE (233 patients)
AMBIEN (232 patients)
TAXOL (227 patients)
SYNTHROID (227 patients)
ATIVAN (224 patients)
PANTOPRAZOLE (220 patients)
RANITIDINE (219 patients)
XELODA (219 patients)
LOVENOX (217 patients)
LANSOPRAZOLE (217 patients)
LAMICTAL (212 patients)
LYRICA (211 patients)
GEMCITABINE (210 patients)
HALAVEN (210 patients)
PERCOCET (210 patients)
NEULASTA (208 patients)
CAPECITABINE (205 patients)
ENBREL (202 patients)
AVASTIN (200 patients)
PROGRAF (197 patients)
OXYCODONE HCL (196 patients)
CLONAZEPAM (196 patients)
BEVACIZUMAB (195 patients)
VITAMIN B-12 (194 patients)
CELEBREX (193 patients)
MABTHERA (193 patients)
FAMOTIDINE (191 patients)
PANTOPRAZOLE SODIUM (188 patients)
CYMBALTA (188 patients)
DURAGESIC-100 (185 patients)
VICODIN (185 patients)
SUTENT (185 patients)
LEVAQUIN (184 patients)
DEPAKOTE (184 patients)
DEPAKENE (183 patients)
LEXAPRO (183 patients)
EPIRUBICIN (179 patients)
CYTARABINE (178 patients)
ZOLOFT (178 patients)
IBUPROFEN (177 patients)
CETUXIMAB (177 patients)
AUGMENTIN '125' (175 patients)
MORPHINE (174 patients)
PLAVIX (174 patients)
WARFARIN SODIUM (174 patients)
KYTRIL (173 patients)
RADIATION THERAPY (173 patients)
VITAMIN D (173 patients)
PROCRIT (170 patients)
MYFORTIC (168 patients)
MULTI-VITAMINS (168 patients)
COMPAZINE (167 patients)
GEMZAR (167 patients)
RAMIPRIL (167 patients)
CAMPATH (166 patients)
AMOXICILLIN (165 patients)
AMLODIPINE (163 patients)
LEVOFLOXACIN (162 patients)
SOLU-MEDROL (161 patients)
ALPRAZOLAM (161 patients)
PREVACID (161 patients)
OLANZAPINE (160 patients)
CITALOPRAM HYDROBROMIDE (160 patients)
CARBAMAZEPINE (160 patients)
CALCIUM CARBONATE (159 patients)
EXJADE (155 patients)
ONDANSETRON (155 patients)
METOPROLOL TARTRATE (154 patients)
HEPARIN (154 patients)
DIFLUCAN (151 patients)
CERTICAN (151 patients)
COPEGUS (151 patients)
METOCLOPRAMIDE (150 patients)
METFORMIN HCL (149 patients)
CAMPTOSAR (148 patients)
TRAMADOL HCL (147 patients)
ALBUTEROL (146 patients)
NAVELBINE (146 patients)
PROCRIT /00909301/ (146 patients)
BISOPROLOL FUMARATE (144 patients)
VALCYTE (142 patients)
PAXIL (142 patients)
PEG-INTRON (141 patients)
LACTULOSE (141 patients)
DIAZEPAM (141 patients)
REBETOL (140 patients)
ZOCOR (140 patients)
ENALAPRIL MALEATE (139 patients)
CELEXA (139 patients)
FLUDARABINE PHOSPHATE (139 patients)
MAGNESIUM OXIDE (138 patients)
MEDROL (138 patients)
CALCIUM (138 patients)
VALTREX (138 patients)
ABILIFY (137 patients)
PEPCID (136 patients)
HYDROCORTISONE (136 patients)
FENTANYL (134 patients)
FERROUS SULFATE TAB (133 patients)
RISPERIDONE (133 patients)
METRONIDAZOLE (132 patients)
CYTOXAN (132 patients)
COLACE (131 patients)
VALPROATE SODIUM (130 patients)
ALDACTONE (130 patients)
ROCEPHIN (129 patients)
MIRTAZAPINE (129 patients)
CLINDAMYCIN (128 patients)
NYSTATIN (128 patients)
COTRIM (127 patients)
DEXAMETHASONE TAB (126 patients)
FLAGYL (126 patients)
MORPHINE SULFATE (126 patients)
CHEMOTHERAPEUTICS NOS (126 patients)
IFOSFAMIDE (126 patients)
ADRIAMYCIN PFS (124 patients)
METOPROLOL (124 patients)
ZANTAC (123 patients)
LAPATINIB (123 patients)
CALCIUM LEVOFOLINATE (123 patients)
ENOXAPARIN SODIUM (122 patients)
EPOGEN (122 patients)
HALDOL (122 patients)
KALETRA (121 patients)
SEROQUEL XR (120 patients)
LAMOTRIGINE (119 patients)
INSULIN (119 patients)
HERCEPTIN (118 patients)
DIGOXIN (118 patients)
LANTUS (116 patients)
ARAVA (116 patients)
PROMETHAZINE (115 patients)
Most common side effects for patients taking AGGRENOX:
HEADACHE (532 patients)
CEREBROVASCULAR ACCIDENT (466 patients)
NAUSEA (408 patients)
DIZZINESS (303 patients)
TRANSIENT ISCHAEMIC ATTACK (267 patients)
VOMITING (254 patients)
ASTHENIA (240 patients)
DIARRHOEA (234 patients)
FATIGUE (182 patients)
PAIN (176 patients)
FALL (170 patients)
PAIN IN EXTREMITY (149 patients)
DYSPNOEA (144 patients)
ANAEMIA (134 patients)
CHEST PAIN (130 patients)
RENAL FAILURE ACUTE (124 patients)
OEDEMA PERIPHERAL (122 patients)
ANXIETY (121 patients)
DEPRESSION (118 patients)
ABDOMINAL PAIN UPPER (113 patients)
HYPOAESTHESIA (112 patients)
HYPERTENSION (110 patients)
HYPOTENSION (105 patients)
MALAISE (104 patients)
CONFUSIONAL STATE (103 patients)
URINARY TRACT INFECTION (99 patients)
RENAL FAILURE (98 patients)
BACK PAIN (98 patients)
PNEUMONIA (96 patients)
WEIGHT DECREASED (95 patients)
ARTHRALGIA (94 patients)
GAIT DISTURBANCE (94 patients)
MYOCARDIAL INFARCTION (89 patients)
PYREXIA (89 patients)
DEHYDRATION (85 patients)
DRUG INEFFECTIVE (83 patients)
COUGH (83 patients)
MYALGIA (79 patients)
ATRIAL FIBRILLATION (79 patients)
CONVULSION (77 patients)
MUSCULAR WEAKNESS (77 patients)
DYSPHAGIA (76 patients)
LOSS OF CONSCIOUSNESS (76 patients)
PRURITUS (73 patients)
SOMNOLENCE (72 patients)
CONSTIPATION (72 patients)
CEREBRAL HAEMORRHAGE (72 patients)
FEELING ABNORMAL (72 patients)
INSOMNIA (71 patients)
ABDOMINAL PAIN (68 patients)
GASTROINTESTINAL HAEMORRHAGE (68 patients)
DECREASED APPETITE (67 patients)
RASH (67 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (66 patients)
HAEMORRHAGE (65 patients)
BLOOD PRESSURE INCREASED (65 patients)
DEATH (62 patients)
DYSPEPSIA (60 patients)
INJURY (59 patients)
BLOOD GLUCOSE INCREASED (59 patients)
SYNCOPE (59 patients)
ABDOMINAL DISCOMFORT (58 patients)
CEREBRAL INFARCTION (57 patients)
VISION BLURRED (57 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (57 patients)
HEMIPARESIS (56 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (56 patients)
RESPIRATORY FAILURE (55 patients)
MUSCLE SPASMS (54 patients)
CONTUSION (54 patients)
MEMORY IMPAIRMENT (54 patients)
NEUROPATHY PERIPHERAL (54 patients)
CARDIAC DISORDER (54 patients)
FLUSHING (53 patients)
HAEMOGLOBIN DECREASED (53 patients)
GASTRITIS (53 patients)
PARAESTHESIA (53 patients)
PALPITATIONS (52 patients)
SINUSITIS (50 patients)
RENAL FAILURE CHRONIC (50 patients)
DYSARTHRIA (50 patients)
EPISTAXIS (49 patients)
HYPERHIDROSIS (48 patients)
CARDIAC FAILURE CONGESTIVE (48 patients)
THROMBOCYTOPENIA (46 patients)
TREMOR (45 patients)
DYSGEUSIA (44 patients)
BALANCE DISORDER (44 patients)
CATARACT (43 patients)
SEPSIS (43 patients)
APHASIA (42 patients)
CORONARY ARTERY DISEASE (41 patients)
DEMENTIA (41 patients)
ABDOMINAL DISTENSION (40 patients)
SPEECH DISORDER (40 patients)
CONDITION AGGRAVATED (40 patients)
DIABETES MELLITUS (40 patients)
OFF LABEL USE (40 patients)
RETCHING (39 patients)
NECK PAIN (39 patients)
BLOOD PRESSURE DECREASED (39 patients)
WEIGHT INCREASED (38 patients)
BLOOD CHOLESTEROL INCREASED (38 patients)
ARTERIOSCLEROSIS (38 patients)
OSTEONECROSIS OF JAW (38 patients)
ATELECTASIS (38 patients)
EMOTIONAL DISTRESS (37 patients)
DIVERTICULUM (37 patients)
DYSPNOEA EXERTIONAL (37 patients)
DUODENAL ULCER (37 patients)
RECTAL HAEMORRHAGE (36 patients)
OSTEOPENIA (36 patients)
DEEP VEIN THROMBOSIS (36 patients)
RIB FRACTURE (36 patients)
CHEST DISCOMFORT (36 patients)
ANHEDONIA (35 patients)
URINARY INCONTINENCE (35 patients)
ABASIA (33 patients)
BLOOD CREATININE INCREASED (33 patients)
HYPERSENSITIVITY (33 patients)
ACUTE MYOCARDIAL INFARCTION (32 patients)
LUNG NEOPLASM MALIGNANT (32 patients)
VERTIGO (32 patients)
CARDIAC ARREST (32 patients)
HYPERLIPIDAEMIA (32 patients)
ERYTHEMA (31 patients)
MENTAL STATUS CHANGES (31 patients)
ISCHAEMIC STROKE (31 patients)
COLONIC POLYP (31 patients)
CAROTID ARTERY STENOSIS (31 patients)
TOOTHACHE (31 patients)
MUSCULOSKELETAL STIFFNESS (31 patients)
OVERDOSE (31 patients)
DYSPHONIA (31 patients)
TOOTH DISORDER (30 patients)
BLINDNESS (30 patients)
NIGHT SWEATS (30 patients)
AGEUSIA (29 patients)
LETHARGY (29 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (29 patients)
INFECTION (29 patients)
HAEMORRHOIDS (29 patients)
BRONCHITIS (29 patients)
URINARY RETENTION (29 patients)
DRY MOUTH (28 patients)
HAEMATURIA (28 patients)
HERPES ZOSTER (28 patients)
CYST (28 patients)
HYPOGLYCAEMIA (28 patients)
HALLUCINATION (28 patients)
HEAD INJURY (28 patients)
NEPHROLITHIASIS (28 patients)
RENAL CYST (28 patients)
EMPHYSEMA (27 patients)
HAEMATOMA (27 patients)
DISORIENTATION (27 patients)
THROMBOSIS (27 patients)
AMNESIA (27 patients)
FOOT FRACTURE (27 patients)
ANOREXIA (27 patients)
PLATELET COUNT DECREASED (27 patients)
INTERVERTEBRAL DISC DEGENERATION (27 patients)
GASTRITIS EROSIVE (27 patients)
CHILLS (27 patients)
ROTATOR CUFF SYNDROME (26 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (26 patients)
WHEEZING (26 patients)
HIP FRACTURE (26 patients)
DRUG INTERACTION (26 patients)
VISUAL IMPAIRMENT (26 patients)
FAECAL INCONTINENCE (25 patients)
SUBDURAL HAEMATOMA (25 patients)
CARDIOMEGALY (25 patients)
INCORRECT DOSE ADMINISTERED (25 patients)
CARDIO-RESPIRATORY ARREST (25 patients)
ORTHOSTATIC HYPOTENSION (25 patients)
CAROTID ARTERY OCCLUSION (25 patients)
BONE PAIN (25 patients)
MITRAL VALVE INCOMPETENCE (25 patients)
OSTEOARTHRITIS (25 patients)
HYPOKALAEMIA (25 patients)
HOT FLUSH (24 patients)
IRRITABLE BOWEL SYNDROME (24 patients)
PULMONARY FIBROSIS (24 patients)
SKIN TIGHTNESS (24 patients)
NOCTURIA (24 patients)
HYPERKALAEMIA (24 patients)
UNRESPONSIVE TO STIMULI (24 patients)
PLEURAL EFFUSION (24 patients)
OSTEOPOROSIS (24 patients)
HEART RATE INCREASED (24 patients)
JOINT SWELLING (24 patients)
TINNITUS (24 patients)
INFLUENZA LIKE ILLNESS (24 patients)
MIGRAINE (24 patients)
METABOLIC ACIDOSIS (23 patients)
RASH GENERALISED (23 patients)
ALANINE AMINOTRANSFERASE INCREASED (23 patients)
ALOPECIA (23 patients)
TACHYCARDIA (23 patients)
OESOPHAGITIS (23 patients)
INFLUENZA (23 patients)
HAEMATEMESIS (23 patients)
SPINAL OSTEOARTHRITIS (23 patients)
HYPERCALCAEMIA (23 patients)
COMA (23 patients)
CEREBRAL ATROPHY (23 patients)
SINUS BRADYCARDIA (23 patients)
AGITATION (22 patients)
TIBIA FRACTURE (22 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AGGRENOX


Issue Description / Topic Timestamp
QUESTION
NEUROPATHY
I am a 76 yr old female and take Aggrenox. Lately I have noticed numbness on the soles of both feet and above one knee to buttock and am trying to determine the cause. My doctor is guessing two pinched spinal nerves and has sent me to physical therapist. I've not noticed a change thus far and am trying to do my own sleuthing. Has anyone else had this reaction to the drug? 2014-11-21 20:22:34
QUESTION
MACULAR DEGENERATION
I've being taking aggrenox for a few years and although i'd recently was diagnosed with macular distrophy, i did not think aggrenox as a probable cause but on the other hand the Dr that diagnosed me told me that since there was no family history nor other facts like look at an eclipse directly etc he found no cause at so early age im 47, my question is, could be my problem a correlated cause of using this medicine, aggrenox? 2014-11-24 19:06:28
QUESTION
MACROGLOSSIA
I began taking Aggrenox Jan 2014. In approx June 2015 I was diagnosed with macroglossia - tongue swelling. Any chance it is caused by Aggrenox? I have been tested for allergies that was negative. Tongue is pushing on front teeth in sleep moving upper jaw significantly. Help! 2015-12-04 17:51:00
QUESTION
BURNING SENSATION
headackes and burning sensation over most of body. Can this be caused by taking Aggrenox? 2016-02-08 19:59:22
QUESTION
DRY MOUTH
Can aggrenox cause dry mouth? 2016-07-31 20:15:08

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about LEUKOPENIA and AGGRENOX, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AGGRENOX, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AGGRENOX. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AGGRENOX experts. If you are a healthcare provider experienced in prescribing AGGRENOX, please register here.

Your online appointment book for Lubbock Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use